Search

NIAID’s R21 call supported basic and translational research on phage biology relevant to preventing and treating drug-resistant bacterial infections. Applications closed on March 18, 2020. The listing gave US$2.5 million as total programme

Recordings from the 2026 Phage therapy 101 course are planned for delivery on November 16, followed by a live Q&A on November 27. phageaustralia.squarespace.com

Flinders researchers explored bacteriophages as a potential treatment for diabetes-related foot ulcers. Flinders University

Established in 2019 and managed by a TU Delft research group, Fagenbank collects bacteria and bacteriophages for research into the efficiency and safety of phage therapy in the Netherlands. Fagenbank — owned project site

Near East University announced that it has isolated NEU2025, a third bacteriophage from a campus pond, found with La Trobe University (Australia); genome analysis places it in the Pbunavirus group and it targets multidrug-resistant Pseudomo

STOA workshop at the European Parliament in Brussels on 30 September 2026 on advancing phage therapy as an evidence-based strategy against antimicrobial resistance, with attention to regulatory, clinical and practical hurdles and to multidr

The House of Commons Science, Innovation and Technology Committee ran an inquiry into the antimicrobial potential of bacteriophages, prompted by a pitch to its My Science inquiry and asking how UK and EU regulation, which has largely limite

The ninth China Phage Therapy Conference and China Phage Research Alliance annual meeting were scheduled for June 26–27, 2026, at Zhongshan Hospital of Fudan University in Shanghai. Via CreatiPhage — Chinese conference notice. Zhongshan Ho

Arrowsmith (Tsukuba, Japan) completed a Series A round totaling ¥1.05 billion, with JAFCO, JIC-VGI and ANRI in the first close and DBJ Capital in the second, and held a pre-IND meeting with the US FDA on ARW001, its phage cocktail for Pseud

The University of Leicester's Becky Mayer Centre for Phage Research (College of Life Sciences; Dr Spyridon Megremis, A Millard, E Galyov, M Clokie) offers self-funded PhD projects covering all aspects of phage biology, from fundamental biol

BiomX has dosed the first cystic fibrosis patient in its Phase 2b trial of BX004 for chronic Pseudomonas aeruginosa infections. Bacteriophage.news

The Phage Center Regensburg announced its 3rd Regensburg Phage Symposium, "Phage Therapy – From Bench to Bedside", for 25 June 2026 (14:00–16:45) in Lecture Hall A2 (Kuno) at the University Hospital Regensburg. The programme lists talks on

In New England Biolabs’ Lessons from Lab & Life podcast, Yale’s Paul Turner expects the next 5 to 10 years to bring more clinical trials of phage therapy against targets such as lung and urinary tract infections, and says engineering phages

Bacteriophage.news announces an affiliate partnership with Parallel Health. The post describes the company’s MD-03 Protocol as combining microbiome sequencing, personalized phage serums and ongoing clinical support. Bacteriophage.news

A Clinical Infectious Diseases case series screened Mycobacterium isolates from 200 patients for phage susceptibility and gave phages intravenously, by aerosolization or both to 20 patients on a compassionate-use basis. No adverse reactions

ASM Health’s work at ASM Microbe included phage therapy, diagnostics, and microbiome medicines. A panel featured Steffanie Strathdee, Vivek Mutalik and Daria Van Tyne, and ASM launched its Phage Therapy Coordination Network. Neha Prasad

The Hooper Shaw Foundation-funded scholarship supports full-time PhD research on bacteriophage-based antimicrobial biotechnology in Sydney’s Faculty of Medicine and Health. It provides the university RTP stipend rate for up to 3.5 years, su

The article outlines a proposed Global Phage Fund that would link revenue from phage products with long-term support for discovery, development, manufacturing standards, regulatory alignment and equitable global access. Sebastian Leptihn

The official abstract book for the 9th World Conference on Targeting Phage Therapy includes over 48 contributions from 24 countries. Topics include phage therapy, One Health, and production, regulation and market access. Targeting Phage The

UCLA Samueli School of Engineering listed chemical engineering PhD graduate Yanxi (Steven) Yang among its 2025 schoolwide awardees, as a Harry M. Showman Prize (graduate) recipient. Yang hosts the "Phage Therapy Today" podcast (20 episodes,